Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice

Fertility and Sterility

Volumn 101, Issue 4, 2014, Pages

  Detti, Laura ^a   Uhlmann, Rebecca A ^a   Zhang, Jie ^a   Diamond, Michael P ^b   Saed, Ghassan M ^c   Fletcher, Nicole M ^c   Lu, Meifen ^a   Williams, Lucy J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclophosphamide; GnRH analogues; goserelin; mice; ovary development; prepubertal

Indexed keywords

CYCLOPHOSPHAMIDE; FOLLITROPIN; GOSERELIN; MUELLERIAN INHIBITING FACTOR;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; BONE GROWTH; CARTILAGE CELL; CONTROLLED STUDY; CORPUS LUTEUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMUR; FOLLITROPIN BLOOD LEVEL; HISTOLOGY; HORMONE BLOOD LEVEL; LEG LENGTHENING; MOUSE; NICK END LABELING; NONHUMAN; OVARY DEVELOPMENT; OVARY FOLLICLE; OVARY INSUFFICIENCY; PREPUBERTY; PRIORITY JOURNAL; UTERUS WEIGHT;

CYCLOPHOSPHAMIDE; GNRH-ANALOGUES; GOSERELIN; MICE; OVARY DEVELOPMENT; PREPUBERTAL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE DEVELOPMENT; CYCLOPHOSPHAMIDE; DRUG INTERACTIONS; FEMALE; GOSERELIN; MICE; MICE, INBRED C57BL; OVARY; PRIMARY OVARIAN INSUFFICIENCY; PUBERTY; TREATMENT OUTCOME;

EID: 84897463746     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.12.028     Document Type: Article

References (27)

1. K. Sarafoglou, F. Boulad, A. Gillio, and C. Sklar Gonadal function after bone marrow transplantation for acute leukemia during childhood J Pediatr 130 1997 210 216
2. W. Chemaitilly, A.C. Mertens, P. Mitby, J. Whitton, M. Stovall, and Y. Yasui et al. Acute ovarian failure in the childhood cancer survivor study J Clin Endocrinol Metab 91 2006 1723 1728
3. D.M. Green, C.A. Sklar, J.D. Boice Jr., J.J. Mulvihill, J.A. Whitton, and M. Stovall et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study J Clin Oncol 27 2009 2374 2381
4. K.C. Oeffinger, A.C. Mertens, C.A. Sklar, T. Kawashima, M.M. Hudson, and A.T. Meadows et al. Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer N Engl J Med 355 2006 1572 1582
5. W.H. Wallace, A.B. Thomson, F. Saran, and T.W. Kelsey Predicting age of ovarian failure after radiation to a field that includes the ovaries Int J Radiat Oncol Biol Phys 62 2005 738 744
6. O. Oktem, and K. Oktay Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function Cancer 110 2007 2222 2229
7. L.E. Bath, W.H. Wallace, M.P. Shaw, C. Fitzpatrick, and R.A. Anderson Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-müllerian hormone, inhibin B and ovarian ultrasound Hum Reprod 18 2003 2368 2374
8. L. Detti, D.C. Martin, R.D. Williams, N. Schlabritz-Loutsevich, L.J. Williams, and R.A. Uhlmann Somatic and reproductive outcomes in mice treated with cyclophosphamide in pre-pubertal age Syst Biol Reprod Med 59 2013 140 145
9. L. Detti, R.A. Uhlmann, M. Lu, M.P. Diamond, G.M. Saed, and N.M. Fletcher et al. Serum markers of ovarian reserve with ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age J Assist Reprod Genet 30 2013 1421 1429
10. Z. Blumenfeld, I. Avivi, M. Ritter, and J.M. Rowe Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women J Soc Gynecol Invest 6 1999 229 239
11. Z. Blumenfeld How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries Oncologist 12 2007 1044 1054
12. D. Meirow, G. Assad, J. Dor, and J. Rabinovici The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice Hum Reprod 19 2004 1294 1299
13. Y. Morita, G.I. Perez, F. Paris, S.R. Miranda, D. Ehleiter, and A. Haimovitz-Friedman et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy Nat Med 6 2000 1109 1114
14. R. Soleimani, E. Heytens, and K. Oktay Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants PLoS One 6 2011 e19475
15. J.S. Jeruss, and T.K. Woodruff Preservation of fertility in patients with cancer N Engl J Med 360 2009 902 911
16. K. Oktay, D.A. Briggs, and R.G. Gosden Ontogeny of FSH receptor gene expression in isolated human ovarian follicles J Clin Endocrinol Metab 82 1997 3748 3751
17. K. Oktay, H. Newton, J. Mullan, and R.G. Gosden Development of human primordial follicles to antral stages in SCID/hpg mice stimulated with follicle stimulating hormone Hum Reprod 13 1998 1133 1138
18. E.A. McGee, and A.J. Hsueh Initial and cyclic recruitment of ovarian follicles Endocr Rev 21 2000 200 214
19. S.E. Osborne, and L. Detti GnRH-analogues for ovarian protection in childhood cancer patients: how adult hypotheses are relevant in prepubertal females Curr Drug Targets 14 2013 856 863
20. C. Decanter, F. Morschhauser, P. Pigny, C. Lefebvre, C. Gallo, and D. Dewailly Anti-müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results Reprod Biomed Online 20 2010 280 285
21. T. Maltaris, M.W. Beckmann, H. Binder, A. Mueller, I. Hoffmann, and H. Koelbl et al. The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice Reproduction 133 2007 503 509
22. H.N. Browne, K.S. Moon, S.L. Mumford, E.F. Schisterman, A.H. Decherney, and J.H. Segars et al. Is anti-Müllerian hormone a marker of acute cyclophosphamide-induced ovarian follicular destruction in mice pretreated with cetrorelix? Fertil Steril 96 2011 180 186
23. J. Blaakaer, M. Baeksted, S. Micic, P. Albrectsen, J. Rygaard, and J. Bock Gonadotropin-releasing hormone agonist suppression of ovarian tumorigenesis in mice of the Wx/Wv genotype Biol Reprod 53 1995 775 779
24. K.E. Dillon, M.D. Sammel, M. Prewitt, J.P. Ginsberg, D. Walker, and J.E. Mersereau et al. Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy Fertil Steril 99 2013 477 483
25. C.J. Xian, J.C. Cool, J. van Gangelen, B.K. Foster, and G.S. Howarth Effects of etoposide and cyclophosphamide acute chemotherapy on growth plate and metaphyseal bone in rats Cancer Biol Ther 6 2007 170 177
26. P.M. Crofton, S.F. Ahmed, J.C. Wade, M.W. Elmlinger, M.B. Ranke, and C.J. Kelnar et al. Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia Pediatr Res 48 2000 490 496
27. R.A. Uhlmann, C. Ogwo, R.W. Williams, S.E. Osborne, L.J. Williams, and L. Detti Somatic and reproductive development in pre-pubertal mice treated with cyclophosphamide and subsequent estrogen replacement Syst Biol Reprod Med 59 2013 337 341